Clinical benefit and quality of life in patients with advanced biliary tract cancer receiving gemcitabine plus capecitabine (GemCap): Results from a multicenter phase II trial (SAKK 44/02)
暂无分享,去创建一个
R. Herrmann | M. Borner | D. Dietrich | P. Saletti | D. Koeberle | W. Mingrone | C. Caspar | D. Gerber | K. Beretta